Imiglucerase

3 trials AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

4 Countries

Phase III

Phase II

Phase III: 2 Phase II: 1

Indications tested

Gaucher´s disease type III 2 Gaucher's disease type I 1 Gaucher´s disease type I 1 Gaucher's disease type III 1

Sponsors using this IMP

Genzyme Corp. 2 Sanofi-Aventis Recherche & Developpement 1

All trials

3 total

Study to evaluate the efficacy and safety of venglustat in adult and pediatric patients with Gaucher disease Type 3 Ended

2024-514381-39-00 Phase III 3 countries Sanofi-Aventis Recherche & Developpement
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Ended

2024-510751-34-00 Phase III 3 countries Genzyme Corp.
Venglustat in Combination with Cerezyme in Adult Patients with Gaucher Disease Type 3 with venglustat monotherapy extension Ended

2023-508646-18-00 Phase II 1 country Genzyme Corp.

Showing 1–3 of 3 trials

← All drugs A–Z